Literature DB >> 22547627

Colistin distribution in the peritoneal fluid of a patient with severe peritonitis.

Olivier Mimoz, Franck Petitpas, Nicolas Grégoire, Patrice Gobin, Sandrine Marchand, William Couet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22547627      PMCID： PMC3393412          DOI： 10.1128/AAC.00478-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  9 in total

Review 1.  Colistin pharmacokinetics: the fog is lifting.

Authors:  W Couet; N Grégoire; S Marchand; O Mimoz
Journal:  Clin Microbiol Infect       Date:  2011-10-11       Impact factor: 8.067

2.  Assay of colistin and colistin methanesulfonate in plasma and urine by liquid chromatography-tandem mass spectrometry.

Authors:  Patrice Gobin; Florian Lemaître; Sandrine Marchand; William Couet; Jean-Christophe Olivier
Journal:  Antimicrob Agents Chemother       Date:  2010-02-22       Impact factor: 5.191

Review 3.  Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections.

Authors:  Jian Li; Roger L Nation; John D Turnidge; Robert W Milne; Kingsley Coulthard; Craig R Rayner; David L Paterson
Journal:  Lancet Infect Dis       Date:  2006-09       Impact factor: 25.071

4.  Pharmacokinetics of colistin and colistimethate sodium after a single 80-mg intravenous dose of CMS in young healthy volunteers.

Authors:  W Couet; N Grégoire; P Gobin; P J Saulnier; D Frasca; S Marchand; O Mimoz
Journal:  Clin Pharmacol Ther       Date:  2011-05-04       Impact factor: 6.875

5.  Kinetics of imipenem distribution into the peritoneal fluid of patients with severe peritonitis studied by microdialysis.

Authors:  Claire Dahyot-Fizelier; Sandrine Lefeuvre; Leila Laksiri; Sandrine Marchand; Ronald J Sawchuk; William Couet; Olivier Mimoz
Journal:  Clin Pharmacokinet       Date:  2010-05       Impact factor: 6.447

6.  Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients.

Authors:  S M Garonzik; J Li; V Thamlikitkul; D L Paterson; S Shoham; J Jacob; F P Silveira; A Forrest; R L Nation
Journal:  Antimicrob Agents Chemother       Date:  2011-05-09       Impact factor: 5.191

7.  International study of the prevalence and outcomes of infection in intensive care units.

Authors:  Jean-Louis Vincent; Jordi Rello; John Marshall; Eliezer Silva; Antonio Anzueto; Claude D Martin; Rui Moreno; Jeffrey Lipman; Charles Gomersall; Yasser Sakr; Konrad Reinhart
Journal:  JAMA       Date:  2009-12-02       Impact factor: 56.272

8.  Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria.

Authors:  D Plachouras; M Karvanen; L E Friberg; E Papadomichelakis; A Antoniadou; I Tsangaris; I Karaiskos; G Poulakou; F Kontopidou; A Armaganidis; O Cars; H Giamarellou
Journal:  Antimicrob Agents Chemother       Date:  2009-05-11       Impact factor: 5.191

9.  Pharmacokinetics of meropenem determined by microdialysis in the peritoneal fluid of patients with severe peritonitis associated with septic shock.

Authors:  J Karjagin; S Lefeuvre; K Oselin; K Kipper; S Marchand; A Tikkerberi; J Starkopf; W Couet; R J Sawchuk
Journal:  Clin Pharmacol Ther       Date:  2007-08-08       Impact factor: 6.875
  9 in total
  2 in total

1.  Pharmacokinetics of colistin methanesulfonate and formed colistin in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis.

Authors:  Pornpan Koomanachai; Cornelia B Landersdorfer; Gong Chen; Hee Ji Lee; Anupop Jitmuang; Somkiat Wasuwattakul; Suchai Sritippayawan; Jian Li; Roger L Nation; Visanu Thamlikitkul
Journal:  Antimicrob Agents Chemother       Date:  2013-11-04       Impact factor: 5.191

Review 2.  Clinical Pharmacokinetics and Pharmacodynamics of Colistin.

Authors:  Nicolas Grégoire; Vincent Aranzana-Climent; Sophie Magréault; Sandrine Marchand; William Couet
Journal:  Clin Pharmacokinet       Date:  2017-12       Impact factor: 6.447
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.